Health Global News & Press Release Distribution

Health

All
APAC

Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport

TOKYO, May 22, 2020 /PRNewswire/ -- Nippon Express (UK) Co., Ltd. (hereinafter, "NEUK"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has been officially granted Wholesale Distribution Authorisation (WDA) and Good Distribution Practice (GDP) certification for its warehouse near L...

2020-05-22 13:00 1482

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Samsung Biologics (207940.KS) have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK's innovative biopharmaceutical therapies. Under the terms of th...

2020-05-22 07:11 6456

Transcenta Announces to Present Preclinical Data of TST001 at 2020 AACR Virtual Annual Meeting II

SUZHOU, China, May 21, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, development and manufacturing, today announced that it will present preclinical data of TST001, a humanized Claudin 18.2 (CLDN18.2) monoclonal ...

2020-05-21 23:00 1609

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

PneumoBlast™ Reduces Pathology and Lung Fluid Accumulation in Model of COVID-19 HOUSTON, May 21, 2020 /PRNewswire/ -- FibroGenesis announced today significant efficacy of its PneumoBlast™ product in an animal model of lung inflammation which resembles COVID-19. Mice immune systems were stimulate...

2020-05-21 22:03 2305

I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme

SHANGHAI, GAITHERSBURG, Md. and SEOUL, South Korea, May 21, 2020 /PRNewswire/ -- I-Mab (NASDAQ: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medi...

2020-05-21 20:00 5850

111, Inc. Announces First Quarter 2020 Unaudited Financial Results

SHANGHAI, May 21, 2020 /PRNewswire/ --111, Inc. ("111" or the "Company") (NASDAQ: YI), a Company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2020. First Quarter 2020 Hi...

2020-05-21 16:30 11200

Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology

MELBOURNE, Austrilia and SAN FRANCISCO, May 21, 2020 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has presented data on ATH434 (formerly PBT434) for the treatment of Multiple System Atrophy at the American Academy of Neurology (AAN) virtual meeting....

2020-05-21 08:58 6148

China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction

BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today declared that Xinjiang Deyuan Bioengineering Co., Ltd. ("Xinjiang Deyuan"), China Biolog...

2020-05-21 04:45 11498

China Biologic Reports Financial Results for the First Quarter of 2020

BEIJING, May 20, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced its unaudited financial results for the first quarter of 2020. First Quarter ...

2020-05-21 04:30 10674

Macrogen Approved for Export of its COVID-19 Test Kit

SEOUL, South Korea, May 20, 2020 /PRNewswire/ -- The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for COVID-19 test kit 'AxenTM COVID-19 RT' from the Ministry of Food and Drug Safety (MFDS) on the 18th. ...

2020-05-20 21:00 1901

Macrogen Approved for Export of its COVID-19 Test Kit

VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock

AUSTIN, Texas, May 20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its NucleosomicsTM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to hel...

2020-05-20 20:45 10870

United Imaging Honored as Multiple Gold Stevie Award Winner in 2020 American Business Awards

HOUSTON, May 20, 2020 /PRNewswire/ -- United Imaging was named the winner of five Stevie® Awards in the 18th Annual American Business Awards® yesterday, including a Gold Award for "Most Innovative Company of the Year - Up to 2,500 Employees" for its U.S.-based operations, which were established i...

2020-05-20 20:00 1337

I-Mab Expands Global Presence with New Hong Kong Office

SHANGHAI and ROCKVILLE, Md., May 20, 2020 /PRNewswire/ -- I-Mab (NASDAQ:IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly ...

2020-05-20 16:00 7835

VSMS ECG Patch receives US FDA 'Emergency Use Authorisation' for patients being treated for COVID-19

* Patch now authorised in the USA for emergency use for patients undergoing treatment for COVID-19 * Patch entitled for reimbursement under US CPT code scheme – adds to GMV's growing revenue profile * Large addressable market for G Medical - ~1.5m confirmed cases of COVID-19 recorded in the...

2020-05-20 10:50 1223

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

SONGDO, South Korea, May 19, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced it has attained ISO22301 certification for additional business operations, demonstrating its unsurpassed commitment to ensuring client satisfaction and operational excellence through its world-class business...

2020-05-20 07:11 1858

Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification

VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

AUSTIN, Texas, May 19, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers a...

2020-05-20 04:01 8488

AI-Powered Data Management for COVID-19 Recovery: Ataccama Offers its Technology to Governments Around the World for Free

TORONTO, May 19, 2020 /PRNewswire/ -- Governments across the globe are struggling to balance restrictive measures to prevent the spread of the Coronavirus and the need to continuously make and adjust decisions around reopening the economy. To accelerate a data-driven response to the Covid-19 pan...

2020-05-19 22:38 1661

WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform

PHILADELPHIA, May 18, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advanced therapies industry, announced today the expansion of its service capabilities to offer a fully int...

2020-05-18 21:00 1988

KT announces collaboration on ICT-based Epidemic Preparedness

SEOUL, South Korea, May 16, 2020 /PRNewswire/ -- KT Corporation (KRX: 030200; NYSE: KT),South Korea's largest telecommunications company, announced a three-year research study today funded by the Bill & Melinda Gates Foundation for ICT-based global epidemic response using artificial intelligence ...

2020-05-17 08:00 5213

KT announces collaboration on ICT-based Epidemic Preparedness

I Peace, Inc. Begins Clinical-Grade Induced Pluripotent Stem Cells Custom Manufacturing Service

PALO ALTO, Calif., May 15, 2020 /PRNewswire/ -- I Peace, Inc. (CEO: Koji Tanabe ), aPalo Alto-based biotech start-up focusing on Nobel Prize-wining technology "induced pluripotent stem cell (iPSC)" began manufacturing clinical-grade iPSCs. We are now officially taking orders for custom manufacturi...

2020-05-16 01:00 2661

1 ... 258 259 260261262 263 264 ... 280